Actinium Pharmaceuticals, Inc.: Form DEF 14A, filed Nov 21, 2022
Filed with the SEC on Nov 21, 2022 and accepted by EDGAR at Nov 21, 2022, 22:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-22-074269. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.